Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...
Mystery infections—persistent and unexplained illnesses—are a rising global health challenge, often delaying critical treatment as patients and clinicians search for answers. Today, advanced genetic ...
A retrospective study highlighted the challenges of genetic testing interpretation for less-represented groups in public databases of genetic variation. The study covered French-Canadians at a large, ...
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...
EU-backed researchers and doctors are pioneering advanced pre-implantation and prenatal genetic testing to improve the chance ...
Once results are ready, patients receive a personalized report and review session with their physician to interpret the findings and discuss tailored next steps. “Salveo Direct Care is at the ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...